Premorbid tobacco smoking is associated with later age at onset in schizophrenia

Psychiatry Research

Volumn 178, Issue 3, 2010, Pages 461-466

  Ma, Xiaohong ^a   Li, Caixia ^a   Meng, Huaqing ^c   Du, Lian ^c   Wang, Qiang ^a   Wang, Yingcheng ^a   Deng, Wei ^a   Liu, Xiehe ^a   Hu, Xun ^a,b   Murray, Robin M ^b   Collier, David A ^b   Li, Tao ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cognition; Duration; Nicotine; Symptom

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIZOPHRENIA; SMOKING HABIT; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TOBACCO DEPENDENCE; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REGRESSION ANALYSIS; SMOKING; TOBACCO USE DISORDER;

ADULT; AGE OF ONSET; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; TOBACCO USE DISORDER;

EID: 77955175438     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.08.014     Document Type: Article

References (64)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin 1998, 24:189-202.
2. Aguilar M.C., Gurpegui M., Diaz F.J., de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. British Journal of Psychiatry 2005, 186:215-221.
3. Ashraf H., Tonnesen P., Holst P.J., Dirksen A., Thorsen H., Dossing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009, 64:388-392.
4. Belluardo N., Mudo G., Blum M., Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behavioural Brain Research 2000, 113:21-34.
5. Beratis S., Katrivanou A., Gourzis P. Factors affecting smoking in schizophrenia. Comprehensive Psychiatry 2001, 42:393-402.
6. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 1998, 155:1490-1501.
7. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry 1999, 156:1328-1335.
8. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 1991, 148:1474-1486.
9. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophrenia Research 2002, 56:47-54.
10. Diaz F.J., de Leon J., Josiassen R.C., Cooper T.B., Simpson G.M. Plasma clozapine concentration coefficients of variation in a long-term study. Schizophrenia Research 2005, 72:131-135.
11. Evans D.A., Beckett L.A., Albert M.S., Hebert L.E., Scherr P.A., Funkenstein H.H., Taylor J.O. Level of education and change in cognitive function in a community population of older persons. Annals of Epidemiology 1993, 3:71-77.
12. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proceedings of the National Academy of Sciences USA 1997, 94:587-592.
13. Gallacher J.E., Elwood P.C., Hopkinson C., Rabbitt P.M., Stollery B.T., Sweetnam P.M., Brayne C., Huppert F.A. Cognitive function in the Caerphilly study: associations with age social class, education and mood. European Journal of Epidemiology 1999, 15:161-169.
14. Genderson M.R., Dickinson D., az-Asper C.M., Egan M.F., Weinberger D.R., Goldberg T.E. Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophrenia Research 2007, 94:231-239.
15. George T.P., Vessicchio J.C., Termine A., Bregartner T.A., Feingold A., Rounsaville B.J., Kosten T.R. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry 2002, 52:53-61.
16. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002, 26:75-85.
17. Glassman A.H. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 1993, 150:546-553.
18. Glynn S.M., Sussman S. Why patients smoke. Hospital & Community Psychiatry 1990, 41:1027-1028.
19. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992, 149:1189-1194.
20. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry 1997, 54:159-165.
21. Gong Y.X. Wechsler Adult Intelligence Scale-Revised in China 1982, Hunan Medical School Press, Hunan.
22. Guan Z.Z., Yu W.F., Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochemistry International 2003, 43:243-249.
23. Gurpegui M., Martinez-Ortega J.M., Aguilar M.C., Diaz F.J., Quintana H.M., de Leon J. Smoking initiation and schizophrenia: a replication study in a Spanish sample. Schizophrenia Research 2005, 76:113-118.
24. Harris J.G., Kongs S., Allensworth D., Martin L., Tregellas J., Sullivan B., Zerbe G., Freedman R. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 2004, 29:1378-1385.
25. Hildebrand,B.E. and Svensson,T.H., 1999. New possibilities in pharmacological treatment of nicotine dependence. Lakartidningen 96, 5217-22, 5224.
26. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
27. Kelly A., Blair N., Pechacek T.F. Women and smoking: issues and opportunities. Journal of Women's Health & Gender-based Medicine 2001, 10:515-518.
28. Kendler K.S., Neale M.C., MacLean C.J., Heath A.C., Eaves L.J., Kessler R.C. Smoking and major depression. A causal analysis. Archives of General Psychiatry 1993, 50:36-43.
29. Kirkland S, Greaves L., Devichand P. Gender differences in smoking and self reported indicators of health. BMC Womens Health 2004, 4(S1):S7.
30. Kumari V., Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioral Reviews 2005, 29:1021-1034.
31. Leonard S., Bertrand D. Neuronal nicotinic receptors: from structure to function. Nicotine & Tobacco Research 2001, 3:203-223.
32. Leonard S., Giordano L. Are differential behavioral responses to smoking and smoking cessation in schizophrenia related to nicotinic receptor levels?. Neuropsychopharmacology 2002, 27:1082-1083.
33. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., Gault J., Lee M.J., Logel J., Olincy A., Ross R.G., Stevens K., Sullivan B., Vianzon R., Virnich D.E., Waldo M., Walton K., Freedman R. Smoking and mental illness. Pharmacology, Biochemistry, and Behavior 2001, 70:561-570.
34. Lezak M. Neuropsychological Assessment 1983, Oxford University Press, New York.
35. Liao D.L., Yang J.Y., Lee S.M., Chen H., Tsai S.J. Smoking in chronic schizophrenic inpatients in Taiwan. Neuropsychobiology 2002, 45:172-175.
36. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Research 1992, 8:93-102.
37. Lu L., Bigler E.D. Performance on original and a Chinese version of Trail Making Test Part B: a normative bilingual sample. Applied Neuropsychology 2000, 7:243-246.
38. Ma X., Wang Q., Sham P.C., Liu X., Rabe-Hesketh S., Sun X., Hu J., Meng H., Chen W., Chen E.Y., Deng W., Chan R.C., Murray R.M., Collier D.A., Li T. Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. American Journal of Medical Genetics B Neuropsychiatry Genetics 2007, 144:407-416.
39. Nelson H.E. A modified card sorting task sensitive to frontal lobe defects. Cortex 1976, 12:313-324.
40. Niu T., Chen C., Ni J., Wang B., Fang Z., Shao H., Xu X. Nicotine dependence and its familial aggregation in Chinese. International Journal of Epidemiology 2000, 29:248-252.
41. Nomikos G.G., Schilstrom B., Hildebrand B.E., Panagis G., Grenhoff J., Svensson T.H. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behavioral Brain Research 2000, 113:97-103.
42. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997, 42:1-5.
43. Olincy A., Johnson L.L., Ross R.G. Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Research 2003, 117:223-236.
44. Patkar A.A., Gopalakrishnan R., Lundy A., Leone F.T., Certa K.M., Weinstein S.P. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. The Journal of Nervous and Mental Disease 2002, 190:604-610.
45. Potter D., Summerfelt A., Gold J., Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophrenia Bulletin 2006, 32:692-700.
46. Rosenfarb I.S., Nuechterlein K.H., Goldstein M.J., Subotnik K.L. Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Archives of General Psychiatry 2000, 57:1174-1179.
47. Sacco K.A., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., George T.P. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 2005, 62:649-659.
48. Sacco K.A., Head C.A., Vessicchio J.C., Easton C.J., Prigerson H.G., George T.P. Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study. Annals of Clinical Psychiatry 2007, 19:89-97.
49. Schilstrom B., Ivanov V.B., Wiker C., Svensson T.H. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology 2007, 32:43-53.
50. Schneider J.S., Tinker J.P., Menzaghi F., Lloyd G.K. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated monkeys. Journal of Pharmacology and Experimental Therapeutics 2003, 306:401-406.
51. Severance E.G., Yolken R.H. Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. Genes, Brain and Behavior 2008, 7:37-45.
52. Sieminska A., Buczkowski K., Jassem E., Lewandowska K., Ucinska R., Chelminska M. Patterns of motivations and ways of quitting smoking among Polish smokers: a questionnaire study. BMC Public Health 2008, 8:274.
53. Smith R.C., Singh A., Infante M., Khandat A., Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 2002, 27:479-497.
54. Smith R.C., Warner-Cohen J., Matute M., Butler E., Kelly E., Vaidhyanathaswamy S., Khan A. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 2006, 31:637-643.
55. Strandburg R.J., Marsh J.T., Brown W.S., Asarnow R.F., Guthrie D., Harper R., Nuechterlein K.H. Continuous-processing related ERPS in adult schizophrenia: continuity with childhood onset schizophrenia. Biological Psychiatry 1999, 45:1356-1369.
56. Tang Y.L., George T.P., Mao P.X., Cai Z.J., Chen Q. Cigarette smoking in Chinese male inpatients with schizophrenia: a cross-sectional analysis. Journal of Psychiatric Research 2007, 41:43-48.
57. Tate J.C., Schmitz J.M. A proposed revision of the Fagerstrom Tolerance Questionnaire. Addictive Behaviors 1993, 18:135-143.
58. Trenerry M.R., Crosson B., DeBoe J., Leber W. The Stroop Neuropsychological Screening Test Psychological Assessment Resources 1989, Odessa, FL.
59. Wang Q., Chan R., Sun J., Yao J., Deng W., Sun X., Liu X., Sham P.C., Ma X., Meng H., Murray R.M., Collier D.A., Li T. Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls. Schizophrenia Research 2007, 89:293-298.
60. Weiser M., Reichenberg A., Grotto I., Yasvitzky R., Rabinowitz J., Lubin G., Nahon D., Knobler H.Y., Davidson M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. American Journal of Psychiatry 2004, 161:1219-1223.
61. Weiser M., Reichenberg A., Rabinowitz J., Knobler H.Y., Lubin G., Yazvitzky R., Nahon D., Gur R.C., Davidson M. Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study. Acta Psychiatrica Scandinavica 2004, 110:471-475.
62. Youdim M.B., Weinstock M. Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cellular and Molecular Neurobiology 2001, 21:555-573.
63. Zammit S., Allebeck P., Dalman C., Lundberg I., Hemmingsson T., Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. American Journal of Psychiatry 2003, 160:2216-2221.
64. Zhang X.Y., Tan Y.L., Zhou D.F., Haile C.N., Wu G.Y., Cao L.Y., Kosten T.A., Kosten T.R. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology 2007, 32:2020-2024.